Biotech News
Filter News
Found 550,941 articles
-
The agreement revolves around the development and commercialization of Pliant’s preclinical candidate, PLN-1474, and up to three more integrin targets for liver fibrosis associated with nonalcoholic steatohepatitis.
-
Because algae can grow simply on carbon dioxide and light, they are attractive to companies looking at generating protein from greenhouse gases.
-
Janice Kranz, the company’s co-founder and chief executive officer took time to speak with BioSpace about the company and its approach to Alzheimer’s disease and other tauopathies.
-
MacroGenics’ metastatic HER2-positive breast cancer treatment margetuximab continues to show promise following a second pre-planned interim overall survival analysis of its Phase III SOPHIA trial.
-
The five scientists on this list collectively made many exciting strides in the field, notably because they had the technological skills to embrace and utilize advances in the realm of computer programming.
-
The drug showed what the company is calling a “substantial improvement in this symptom-driven score” at the 12-week point, but it did not differentiate from placebo.
-
Good Pharma Scorecard Continues to Boost Clinical Trial Transparency, Analyst Report Shows
10/23/2019
Calls for increased transparency in clinical trials have been growing and now many medical journals are requiring authors of submitted papers to disclose whether or not they will be sharing clinical trial results. -
Segal Trials Acquires New Studies with Schedule 1 DEA License and Continues to Expand its Network of Inpatient and Outpatient Facilities
10/23/2019
Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I–IV trials, has been named one of seven sites to begin a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive disorder (MDD).
-
HEXO Corp announces $70 million private placement of convertible debentures led by Directors, CEO, and long-term shareholders; reschedules FY 2019 earnings call
10/23/2019
HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) today announced that it has entered into subscription agreements with a group of investors pursuant to which the investors have agreed to purchase, on a private placement basis, $70 million principal amount of 8.0% unsecured convertible debentures of the Company (the “Debentures”).
-
Duke Clinical Research Institute to Lead Pragmatic Study to Assess Effectiveness of Statins in Older Adults
10/23/2019
Building on its success in leading pragmatic approaches for clinical study design, the Duke Clinical Research Institute (DCRI), part of the Duke University School of Medicine, has been awarded funding to conduct a pragmatic trial studying the effectiveness of statins in older adults without known cardiovascular disease
-
Leading Doctor Says Magnesium Deficiencies Are One Of The Most Overlooked Problems In Conventional Medicine
10/23/2019
Magnesium is the fourth most abundant mineral in the body, spearheading more than 300 biochemical reactions, yet as many as 90% of people are deficient, a nationally regarded doctor tells the Epsom Salt Council.
-
Matrix Medical Network Achieves HITRUST CSF® CertificationHITRUST CSF Certification validates Matrix’s commitment to meeting key healthcare regulations and protecting sensitive private healthcare information
10/23/2019
Matrix Medical Network (Matrix), a leading provider of in-home and mobile health clinic assessments and care management, announced its systems have again earned Certified Status for information security by the Health Information Trust (HITRUST) Alliance
-
Illinois American Water Customers Urged to Participate in National Drug Take Back Day on Saturday, Oct. 26, 2019
10/23/2019
This coming Saturday, Oct. 26, 2019, from 10 AM to 2 PM, the U.S. Drug Enforcement Administration (DEA) will host its 18th National Drug Take Back Day in nine years.
-
Cheetah Medical Presents Correlation Between Starling™ SV Use and Sepsis Management at the CHEST Annual Meeting 2019 International Conference
10/23/2019
Cheetah Medical, a medical device leader in non-invasive fluid management technology, today delivered a presentation at the American College of Chest Physicians’ Annual Meeting in New Orleans, Louisiana, showing that hospitals with the highest use of Cheetah Medical’s Starling SV™ exhibited the greatest levels of compliance with The Center for Medicare and Medicaid Services sepsis (SEP-1) measures.
-
Ambry Genetics Published Data that Finds Adding RNA Genetic Testing Provides More Accurate, Actionable Results for Patients who Receive DNA Testing for Hereditary Cancer Risk
10/23/2019
Ambry Genetics® (Ambry), a leading clinical genetics company, announced today the publication in JAMA Network Open of a study on retrospective RNA genetic testing for hereditary cancer risk
-
Study reveals barriers to obtaining overdose-reversing drug naloxone in pharmacies, especially for teens
10/23/2019
The primary sample group in Dr. Adesman's study included 120 pharmacies in the 10 states with the highest number of opioid-related overdose deaths in 2016.
-
Pega Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
10/23/2019
Pegasystems Inc. (NASDAQ: PEGA), the software company empowering digital transformation at the world's leading enterprises, today announced Pega Cloud® has earned certified status for information security by HITRUST.
-
ABC Financial and Trek Announce Vendor Partnership
10/23/2019
ABC Financial (ABC), the leading software and payment processing provider to the health and fitness industry, today announced their preferred partnership with Trek CCM, LLC.
-
Fourth-IR, Incyte, and Xylem Receive "Tell Awards" for FDI in Switzerland
10/23/2019
Since 2005, 50 American companies have won this prestigious award named for the legendary Swiss folk hero William Tell.
-
ECRI Institute: Diagnostic Tests, Medication Pose Biggest Risks to Patients in Ambulatory Care
10/23/2019
New research from ECRI Institute, the nation's leading independent, non-profit patient safety organization, reveals that diagnostic testing and medication events are the most frequent safety risks patients face in ambulatory care.